Drug
Odm 101 Carbidopa
Odm 101 Carbidopa: highest development phase Phase 2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-101 65mg Carbidopa NCT01766258 | Phase 2 | Parkinson's Disease |
Latest
No recent events.
Follow Odm 101 Carbidopa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.